Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025 GlobeNewswire October 17, 2025 Preclinical data for CLYM116, anti-APRIL monoclonal antibody, highlight favorable pharmacokinetic and pharmacodynamic profile, supporting development for IgA nephropathy (IgAN) Long-term follow-up clinical data for budoprutug, anti-CD19 monoclonal antibody, support potential for therapeutic benefit in primary membranous nephropathy […]

Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease GlobeNewswire October 17, 2025 Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease Paris, October 17, 2025. The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has

New Crypto Mutuum Finance (MUTM) Nears $20M in Funding With V1 Launch Scheduled for Q4 2025 GlobeNewswire October 17, 2025 Dbai, UAE , Oct. 17, 2025 (GLOBE NEWSWIRE) — The crypto industry is entering a new phase where utility-focused protocols are starting to gain serious traction. One of the clearest examples of this shift is

XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems Acquisition includes novel new chemical entity VB4-P5 with potential to address significant unmet needs in rare and large-market kidney diseases GlobeNewswire October 17, 2025 CALGARY, Alberta, Oct. 17, 2025 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company“) (NASDAQ: XRTX | TSXV: XRTX

Emerita Extends El Cura Deposit 90 Meters Westward, Intersecting 4.1 Meters Grading 3.9% copper, 3.6% lead 8.5% Zinc, 4.08 g/t gold and 96.4 g/t silver GlobeNewswire October 17, 2025 TORONTO, Oct. 17, 2025 (GLOBE NEWSWIRE) — Emerita Resources Corp. (TSX-V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) announces ongoing diamond drilling results that

Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting Conference call and webcast to discuss results to be held on November 7, 2025 at 8:00 a.m. ET GlobeNewswire October 17, 2025 IRVINE, Calif.,

Guardian Capital Announces October 2025 Cash Distributions for Guardian Capital ETFs GlobeNewswire October 17, 2025 TORONTO, Oct. 17, 2025 (GLOBE NEWSWIRE) — Guardian Capital LP (the “Manager”) announces the following regular cash distributions for the period ending October 31, 2025, in respect of the ETF series of the Guardian Capital funds listed below (the “Guardian

Tonix Pharmaceuticals Presented Data on TNX-801 Mpox Vaccine at World Vaccine Congress-Europe 2025 GlobeNewswire October 17, 2025 TNX-801 is a live virus vaccine investigational candidate, designed to provide durable protection against mpox and smallpox TNX-801 demonstrated favorable safety, immunogenicity, and long-term protection in multiple preclinical models Data support advancement of TNX-801 toward clinical development CHATHAM,

Rafael Nuissier Introduces “The Funnel Formula” and New Website to Empower Businesses With Predictable Growth Strategies Miami-based entrepreneur introduces practical frameworks for turning online engagement into measurable revenue results GlobeNewswire October 17, 2025 Miami, Florida, Oct. 17, 2025 (GLOBE NEWSWIRE) — Revenue optimization expert Rafael Nuissier today announced the official launch of his new book,

(NYSE:PLX), PARMA, Italy and CARMIEL, Israel, Oct. 17, 2025 (GLOBE NEWSWIRE) — Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, and Protalix BioTherapeutics, Inc. (NYSE American:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic